The Treatments for Low-Risk Prostate Cancer
10.22465/kjuo.2019.17.1.7
- Author:
Jeong Woo LEE
1
;
Jae Young JEONG
;
In Chang CHO
;
Sung Han KIM
;
Whi An KWON
;
Miyoung CHOI
;
Jeong Kyun YEO
Author Information
1. Department of Urology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
- Publication Type:Review
- Keywords:
Prostatic neoplasms;
Treatment-related cancers;
Evidence-based medicine
- MeSH:
Aged;
Diagnosis;
Evidence-Based Medicine;
Humans;
Korea;
Life Expectancy;
Lymph Node Excision;
Mass Screening;
Medical Overuse;
Neoplasms, Second Primary;
Prevalence;
Prostate;
Prostate-Specific Antigen;
Prostatectomy;
Prostatic Neoplasms;
Watchful Waiting
- From:Korean Journal of Urological Oncology
2019;17(1):7-21
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Recently, the prevalence of prostate cancer has been increased with the screening of prostate-specific antigen and the increase in the elderly population. In particular, the diagnosis of the low-risk prostate cancer has increased greatly, and social interest for overtreatment has been heightened in Korea. Therefore, this review aimed to provide evidence-based treatment guidelines in low-risk prostate cancer based on Korean population. The literature provides evidence on treatment options, such as watchful waiting, active surveillance, radical prostatectomy, and radiation therapy according to the life expectancy of patients with low-risk prostate cancer. Furthermore, this review provides information on the efficacy of pelvic lymph node dissection and adjuvant radiation therapy during/after radical prostatectomy in low-risk prostate cancer.
